Glioma-Specific Diffusion Signature in Diffusion Kurtosis Imaging.
diffusion kurtosis imaging
diffusion signature
glioma
mean diffusivity
mean kurtosis
segmentation
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
26 May 2021
26 May 2021
Historique:
received:
28
03
2021
revised:
17
05
2021
accepted:
20
05
2021
entrez:
2
6
2021
pubmed:
3
6
2021
medline:
3
6
2021
Statut:
epublish
Résumé
This study aimed to assess the relationship between mean kurtosis (MK) and mean diffusivity (MD) values from whole-brain diffusion kurtosis imaging (DKI) parametric maps in preoperative magnetic resonance (MR) images from 2016 World Health Organization Classification of Tumors of the Central Nervous System integrated glioma groups. Seventy-seven patients with histopathologically confirmed treatment-naïve glioma were retrospectively assessed between 1 August 2013 and 30 October 2017. The area on scatter plots with a specific combination of MK and MD values, not occurring in the healthy brain, was labeled, and the corresponding voxels were visualized on the fluid-attenuated inversion recovery (FLAIR) images. Reversely, the labeled voxels were compared to those of the manually segmented tumor volume, and the Dice similarity coefficient was used to investigate their spatial overlap. A specific combination of MK and MD values in whole-brain DKI maps, visualized on a two-dimensional scatter plot, exclusively occurs in glioma tissue including the perifocal infiltrative zone and is absent in tissue of the normal brain or from other intracranial compartments. A unique diffusion signature with a specific combination of MK and MD values from whole-brain DKI can identify diffuse glioma without any previous segmentation. This feature might influence artificial intelligence algorithms for automatic tumor segmentation and provide new aspects of tumor heterogeneity.
Identifiants
pubmed: 34073442
pii: jcm10112325
doi: 10.3390/jcm10112325
pmc: PMC8199055
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Radiology. 2010 Mar;254(3):876-81
pubmed: 20089718
PLoS One. 2014 May 07;9(5):e96873
pubmed: 24804720
Clin Neurol Neurosurg. 2016 Dec;151:120-127
pubmed: 27825037
N Engl J Med. 2005 Mar 10;352(10):997-1003
pubmed: 15758010
J Magn Reson Imaging. 2015 Nov;42(5):1190-202
pubmed: 26119267
Clin Oncol (R Coll Radiol). 2017 Jan;29(1):15-25
pubmed: 27743773
Radiology. 2008 Jun;247(3):808-17
pubmed: 18487536
J Clin Epidemiol. 2008 Apr;61(4):344-9
pubmed: 18313558
Acta Neuropathol. 2020 Mar;139(3):603-608
pubmed: 31996992
Neuroimage Clin. 2019;22:101727
pubmed: 30825711
Acta Neuropathol. 2015 Jan;129(1):133-46
pubmed: 25427834
J Neurooncol. 2017 Jan;131(1):93-101
pubmed: 27604789
Radiology. 2016 Dec;281(3):907-918
pubmed: 27636026
Nat Rev Clin Oncol. 2018 Feb;15(2):112-125
pubmed: 29158591
Acta Neuropathol Commun. 2016 Jun 16;4(1):60
pubmed: 27311324
NMR Biomed. 2006 Apr;19(2):236-47
pubmed: 16521095
Mod Pathol. 2013 Nov;26(11):1425-32
pubmed: 23765250
J Neurooncol. 2017 Jan;131(2):393-402
pubmed: 27837437
AJNR Am J Neuroradiol. 2014 Mar;35(3):498-503
pubmed: 23988756
Lancet. 2017 Oct 7;390(10103):1645-1653
pubmed: 28801186
Eur Radiol. 2018 Aug;28(8):3306-3317
pubmed: 29536240
Eur J Radiol. 2019 Mar;112:144-152
pubmed: 30777204
J Neurooncol. 2019 Jan;141(1):195-203
pubmed: 30414095
Neuroradiology. 2016 Dec;58(12):1217-1231
pubmed: 27796448
AJNR Am J Neuroradiol. 2006 Oct;27(9):1969-74
pubmed: 17032877
Radiology. 2012 May;263(2):492-501
pubmed: 22403168
NMR Biomed. 2014 Feb;27(2):202-11
pubmed: 24738143
IEEE Trans Med Imaging. 2010 Mar;29(3):819-29
pubmed: 20199917
BMJ Open. 2018 Dec 14;8(12):e025123
pubmed: 30552282
Acta Neuropathol. 2014 Oct;128(4):551-9
pubmed: 25143301
Acta Neuropathol. 2015 Jun;129(6):867-73
pubmed: 25962792
Acta Neuropathol. 2017 Jun;133(6):1001-1016
pubmed: 28255664
Lancet Oncol. 2017 Jun;18(6):e315-e329
pubmed: 28483413
Magn Reson Med. 2005 Jun;53(6):1432-40
pubmed: 15906300
J Neurooncol. 2020 Jan;146(1):157-162
pubmed: 31797235
Oncologist. 2006 Jun;11(6):681-93
pubmed: 16794247
Acta Neuropathol. 2015 Sep;130(3):407-17
pubmed: 26087904
PLoS One. 2013 May 21;8(5):e63462
pubmed: 23704910
Nat Genet. 2015 May;47(5):458-68
pubmed: 25848751
Neurol India. 2016 Mar-Apr;64(2):265-72
pubmed: 26954804
NMR Biomed. 2007 Feb;20(1):49-57
pubmed: 16986106
IEEE J Biomed Health Inform. 2019 Jan;23(1):38-46
pubmed: 29993901
J Neuroradiol. 2018 Feb;45(1):32-40
pubmed: 28865921
Expert Rev Mol Diagn. 2017 Jan;17(1):83-94
pubmed: 27893285
Acta Neuropathol. 2015 Apr;129(4):585-96
pubmed: 25701198
Acta Neuropathol. 2016 Jun;131(6):803-20
pubmed: 27157931
Eur J Radiol. 2017 Oct;95:202-211
pubmed: 28987669
NMR Biomed. 2010 Aug;23(7):698-710
pubmed: 20632416
N Engl J Med. 2005 Mar 10;352(10):987-96
pubmed: 15758009
J Neuroradiol. 2008 Oct;35(4):224-9
pubmed: 18420272
Radiol Oncol. 2017 Feb 15;51(2):121-129
pubmed: 28740446
JAMA Oncol. 2016 Nov 1;2(11):1460-1469
pubmed: 27310651